药物对比
Dihydroergotamine vs Ubrogepant
比较Dihydroergotamine与Ubrogepant治疗偏头痛。DHE有血管风险黑框警告；Ubrelvy是更安全的CGRP口服选择。
此页面暂无可用的对比维度。
临床背景
Patients exploring acute migraine options when switching from older ergots like DHE to newer gepants amid cardiovascular concerns.
结论
Ubrogepant generally provides a safer profile for most, though dihydroergotamine remains viable for select refractory cases.
全部药物对比